Renal Cell Carcinoma (gp200) Antibody (3G4) Summary

j.jtcme.2015.08.008

Renal Cell Carcinoma (gp200) Antibody (3G4) Summary

    Immunogen
    LY75 (NP_002340, 37 a.a. – 135 a.a.) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. TIVHGNTGKCIKPVYGWIVADDCDETEDKLWKWVSQHRLFHLHSQKCLGLDITKSVNELRMFSCDSSAMLWWKCEHHSLYGAARYRLALKDGHGTAIS*
    Specificity
    LY75 (3G4)
    Isotype
    IgG2b Kappa
    Clonality
    Monoclonal
    Host
    Mouse
    Gene
    LY75
    Purity
    IgG purified
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        ELISA
    Application Notes
    Antibody reactivity against recombinant protein on ELISA. GST alone used as a negative control.

Packaging, Storage & Formulations

    Storage
    Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
    Buffer
    PBS (pH 7.4)
    Preservative
    No Preservative
    Purity
    IgG purified

Notes

Quality control test: Antibody Reactive Against Recombinant Protein.

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for Renal Cell Carcinoma (gp200) Antibody (3G4)

      CD205LY-75
      CLEC13BLy-75
      C-type lectin domain family 13 member B
      DEC-205CD205 antigen
      GP200-MR6
      lymphocyte antigen 75

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Tozasertib